Thrive Earlier Detection Taps CVS’s Asgarian as Chief Medical Officer

Cancer diagnostics developer Thrive Earlier Detection has named Sam Asgarian its chief medical officer. He joins Thrive from CVS Health (NYSE: [[ticker:CVS]]), where he was vice president of the company’s transformation health product divison. He came to CVS via its acquisition of Aetna.

In other moves, Dina Ciarimboli, who had been serving as interim general counsel, was appointed Thrive’s chief legal officer. Cambridge, MA-based Thrive is developing tests that detect early signs of cancer from a small sample of blood. In July, the company raised $257 million in Series B financing to fund a pivotal test of its liquid biopsy technology.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.